RXULTI

brexpiprazole · Otsuka Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RXULTI, covering 2025-12-05 to 2026-07-29. Get the full timeline:

Most recent: EMA Authorised: Rxulti (brexpiprazole) — Otsuka Pharmaceutical Netherlands B.V.